# Variational Autoencoders for Generative Drug-Gene Interactions in Periodontal Bone Resorption

**Authors:** Pradeep Kumar Yadalam, Ramya Ramadoss, Raghavendra Vamsi Anegundi

PMC · DOI: 10.7759/cureus.65886 · Cureus · 2024-07-31

## TL;DR

This paper uses variational autoencoders to generate drug-gene interactions for periodontal bone resorption, identifying key genes and validating the model's accuracy.

## Contribution

The novel use of VAEs to model and generate drug-gene interactions in periodontal bone resorption is presented.

## Key findings

- Top hub genes like MMP14, MMP9, HIF1A, and STAT1 were identified in drug-gene interactions.
- The VAE model achieved a mean squared error of 0.077 and a KL divergence of 2.349.
- The model accurately represents complex drug-gene relationships in bone resorption.

## Abstract

Introduction

Periodontal bone resorption is a significant dental problem causing tooth loss and impaired oral function. It is influenced by factors such as bacterial plaque, genetic predisposition, smoking, systemic diseases, medications, hormonal changes, and poor oral hygiene. This condition disrupts bone remodeling, favoring resorptive processes. Variational autoencoders (VAEs) can learn the distribution of drug-gene interactions from existing data, identify potential drug targets, and predict therapeutic effects. This study investigates the generation of drug-gene interactions in periodontal bone resorption using VAEs.

Methods

A bone resorptive drugs dataset was retrieved from Probes and Drugs and analyzed using Cytoscape (https://cytoscape.org/) and CytoHubba (https://apps.cytoscape.org/apps/cytohubba), powerful tools for studying drug-gene interactions in bone resorption. The dataset was then prepared for matrix representation, with normalized input data. It was subsequently divided into training, validation, and testing sets. We then built an encoder-decoder network, defined a loss function, optimized parameters, and fine-tuned hyperparameters. Using VAEs, we generated new drug-gene interactions, assessed model performance, and visualized the latent space with reconstructed drug-gene interactions for further insights.

Results

The analysis revealed the top hub genes in drug-gene interactions, including Matrix Metalloproteinase (MMP) 14, MMP 9, HIF1A, STAT1, MAPT, CAS9, MMP2, CASP3, MMP1, and MAK1. The VAE's reconstruction accuracy was measured using mean squared error (MSE), with an average squared difference of 0.077. Additionally, the KL divergence value was 2.349, and the average reconstruction log-likelihood was -246.

Conclusion

The generative variational encoder model for drug-gene interactions in bone resorption demonstrates high accuracy and reliability in representing complex drug-gene relationships within this context.

## Linked entities

- **Genes:** MMP14 (matrix metallopeptidase 14) [NCBI Gene 4323], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772], MAPT (microtubule associated protein tau) [NCBI Gene 4137], cas9 (type II CRISPR RNA-guided endonuclease Cas9) [NCBI Gene 2741543], MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313], CASP3 (caspase 3) [NCBI Gene 836], MMP1 (matrix metallopeptidase 1) [NCBI Gene 4312], mak-1 (MAP kinase-activated protein kinase mak-1) [NCBI Gene 174398]

## Full-text entities

- **Genes:** HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, MMP1 (matrix metallopeptidase 1) [NCBI Gene 4312] {aka CLG}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}
- **Diseases:** tooth loss (MESH:D016388), bone resorption (MESH:D001862), systemic diseases (MESH:D034721), Periodontal Bone Resorption (MESH:D016301), impaired oral function (MESH:D003072)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11364490/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11364490/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC11364490/full.md

---
Source: https://tomesphere.com/paper/PMC11364490